Hear from Xstrahl’s CEO, Adrian Treverton and Technical Service Manager, Wilfried Goetz about increasing throughput in SARRP research with a variety of mouse beds. Radiation research can be done on multiple subjects at once.
SARRP Mediated Focal Radiotherapy of Triple-Negative Breast Cancer
In the study, Radiotherapy-exposed CD8+ and CD4+ Neoantigens Enhance Tumor Control, SARRP enabled researchers to verify that radiotherapy works in concert with neoantigen vaccination to improve tumor control. See more below, and the full study here.
